Glenmark partners with Pfizer to launch Abrocitinib in India
When launched in India, it will be co-marketed under the brand names JABRYUS and CIBINQO by Glenmark and Pfizer respectively
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
marketing authorisation
Orchid Pharma gets EMA approval for Exblifep
Exblifep has received EMA's recommendation for marketing authorization for use in treatment of complicated urinary tract…
Venus Remedies gets marketing approval from Israel, Colombia for two oncology drugs
The company has received marketing authorisation for docetaxel from Israel and cytarabine from Colombia
Venus Remedies gets marketing approvals from Philippines, Saudi Arabia for three drugs
While Saudi Arabia is the largest pharma market in GCC region, Philippines happens to be the second largest market in South East…
Biocon Biologics gets EC approval for YESAFILI, biosimilar Aflibercept
The EC decision follows the European Medicines Agency’s CHMP positive opinion recommending approval of YESAFILI in July
Venus Remedies gets marketing approval for gemcitabine and docetaxel from Serbia
With this, the company has secured 511 marketing approvals for its oncology products across 66 countrles
Venus Remedies gets marketing approval from Saudi for Docetaxel
This marketing authorisation from the largest GCC market will enable Venus Remedies to establish a strong foothold in GCC and MENA…
Venus Remedies gets marketing authorisation from UK MHRA for Cisplatin
The company intends to increase sales in the UK to approximately two million euros by focusing on seven molecules which are…
Sanofi gets marketing approval for its diabetes drug Soliqua in India
Pre-filled pens containing a combination of insulin glargine 100 Units/mL and lixisenatide for once-daily dosing
Pfizer and Opko’s Ngenla injection gets marketing authorisation in EU
Ngenla provides pediatric patients, their caregivers and healthcare providers with a new treatment option for Growth Hormone…